0000000000686785

AUTHOR

M. Napolitano

showing 33 related works from this author

Measurement of σ(e+e−→π+π−) from threshold to 0.85 GeV2 using initial state radiation with the KLOE detector

2011

Measurement of σ(e+e−→π+π−) from threshold to 0.85 GeV2 using initial state radiation with the KLOE detector

Nuclear physicsPhysicsNuclear and High Energy PhysicsElectron–positron annihilationDetectorState (functional analysis)RadiationPhysics Letters B
researchProduct

Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience

2011

Adverse events Inherited Factor VII deficiency
researchProduct

Acquired Hemophilia A Associated with Venous Thrombosis and Very High Inhibitor Titer: A Challenging Scenario

2019

medicine.medical_specialtyVenous thrombosisbusiness.industryInternal medicineAcquired hemophiliaAcquired haemophilia high inhibitor venous thrombosisMedicineGeneral MedicinebusinessBypassing agentmedicine.diseaseGastroenterologyAnnals of Hematology & Oncology
researchProduct

Measurement of the branching ratio and search for a CP violating asymmetry in the η→π+π−e+e−(γ) decay at KLOE

2009

Abstract We have studied the η → π + π − e + e − ( γ ) decay using about 1.7 fb − 1 collected by the KLOE experiment at the DAΦNE ϕ -factory. This corresponds to about 72 millions η mesons produced in ϕ radiative decays. We have measured the branching ratio, inclusive of radiative effects, with 4% accuracy: BR ( η → π + π − e + e − ( γ ) ) = ( 26.8 ± 0.9 Stat . ± 0.7 Syst . ) × 10 − 5 . We have obtained the first measurement of the CP-odd ππ – ee decay planes angular asymmetry, A ϕ = ( − 0.6 ± 2.5 Stat . ± 1.8 Syst . ) × 10 − 2 .

PhysicsNuclear and High Energy PhysicsParticle physicsMesonBranching fractionmedia_common.quotation_subjectGamma rayPiRadiative transferCP violationAsymmetrymedia_commonPhysics Letters B
researchProduct

Search for heavy neutrinos at the NA48/2 and NA62 experiments at CERN

2018

© The Authors, published by EDP Sciences. The NA48/2 experiment at CERN has collected large samples of charged kaons decaying into a pion and two muons for the search of heavy nuetrinos. In addition, its successor NA62 has set new limits on the rate of charged kaon decay into a heavy neutral lepton (HNL) and a lepton, with = e, µ, using the data collected in 2007 and 2015. New limits on heavy neutrinos from kaon decays into pions, muons and positrons are presented in this report.

PhysicsParticle physicsLarge Hadron ColliderMuonPhysics::Instrumentation and Detectors010308 nuclear & particles physicsPhysicsQC1-999Nuclear TheoryHigh Energy Physics::PhenomenologyHeavy neutrino01 natural sciencesSettore FIS/04 - Fisica Nucleare e SubnuclearePhysics and Astronomy (all)Pion0103 physical sciencesHigh Energy Physics::ExperimentKaon decaysNeutrinoHeavy neutrinoNuclear Experiment010306 general physicsKaon decays Heavy neutrinoParticle Physics - ExperimentLepton
researchProduct

Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors.

2009

Combined deficiency of the vitamin K-dependent clotting factors (VKCFD) is a rare bleeding disorder involving defective gamma-carboxylation of coagulation factors II , VII, IX and X as well as natural anticoagulants protein C and protein S. The disease is characterized by a cluster of different, often life threatening, bleeding symptoms occurring both spontaneously and in a surgical setting. In the present paper we describe two different treatment modalities to be used both in a programmed surgical procedure and in an emergency scenario. As this disease is a natural model that resembles oral anticoagulation, our experience discloses a possible rationale in the use of recombinant activated …

VitaminAdultmedicine.medical_specialtyVitamin KBiopsyFactor VII DeficiencyHereditary Combined Deficiency of Vitamin K-dependent Clotting FactorsBlood Loss SurgicalDiseaseFactor VIIaGastroenterologyMixed Function Oxygenaseschemistry.chemical_compoundBlood Coagulation Disorders InheritedInternal medicineVitamin K Epoxide ReductasesGastroscopymedicineHumansRare Inherited Bleeding disorders Minor SurgeryOral anticoagulationClotting factorbusiness.industryHomozygoteWarfarinHematologyGeneral MedicineFactor VIIHemostasis SurgicalRecombinant ProteinsSurgeryCoagulationchemistryHemostasisTooth ExtractionFemaleBlood Coagulation TestsbusinessProtein Cmedicine.drugClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
researchProduct

Observation of the rare η→e+e−e+e− decay with the KLOE experiment

2011

Abstract We report the first observation of the rare η → e + e − e + e − ( γ ) decay based on 1.7 fb − 1 collected by the KLOE experiment at the DAΦNE ϕ-factory. The selection of the e + e − e + e − final state is fully inclusive of radiation. We have identified 362 ± 29 events resulting in a branching ratio of ( 2.4 ± 0.2 stat + bckg ± 0.1 syst ) × 10 − 5 .

PhysicsNuclear physicsNuclear and High Energy PhysicsParticle physics010308 nuclear & particles physicsBranching fractionElectron–positron annihilation0103 physical sciencesRadiation010306 general physics01 natural sciencesPhysics Letters B
researchProduct

Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report

2012

Transplantation in patients with congenital bleeding disorders is a challenge requiring an integrated approach of various specialists. Renal transplantation, the most frequent type of solid organ transplantation, is rarely performed in individuals with congenital hemorrhagic disorders. We performed a renal transplantation in a 53-year-old man with end-stage renal disease and congenital coagulation factor VII deficiency, a rare bleeding disorder with a peculiar clinical picture requiring replacement therapy in surgical interventions. Perioperative bleeding was successfully prevented by administration of recombinant activated factor VII. Treatment schedule, administration rate, and long-term …

Malemedicine.medical_specialtyDiseaseHemorrhagic disorderchemistry.chemical_compoundHumansMedicinekidney transplatation congenital bleeding disorders factor VII deficiency recombinant factor VII major surgerykidney transplantation inherited coagulation disorderCoagulation factor VIIKidney transplantationTransplantationFactor VIIbusiness.industryPerioperativeMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationchemistryTreatment ScheduleFeasibility StudiesKidney Failure ChronicSurgerybusiness
researchProduct

Searches for lepton number violating $K^+$ decays

2019

The NA62 experiment at CERN reports a search for the lepton number violating decays K+ -> pi(-)e(+)e(+) and K+ -> pi(-)mu(+)mu(+) using a data sample collected in 2017. No signals are observed, and upper limits on the branching fractions of these decays of 2.2 x 10(-10) and 4.2 x 10(-11) are obtained, respectively, at 90% confidence level. These upper limits improve on previously reported measurements by factors of 3 and 2, respectively.

branching ratio: upper limitK+: rare decayNA62 experiment01 natural sciencesNA62Settore FIS/04 - Fisica Nucleare e SubnucleareHigh Energy Physics - Experimentelectron: pair productionHigh Energy Physics - Experiment (hep-ex)EconomicaK+: branching ratio[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]K meson decayPhysicsLarge Hadron ColliderElectroweak interactionlcsh:QC1-999muon: pair productionlepton number violationK+: semileptonic decayK+: secondary beamParticle Physics - ExperimentNuclear and High Energy PhysicsParticle physicsCERN LabS010.46FOS: Physical scienceskaonsS010:Desig=46K+ --> pi- 2muon+Partícules (Física nuclear)PE2_2Violació CP (Física nuclear)0103 physical sciencesKaon decayslepton number violation K meson K meson decay010306 general physicslepton number: violationKaon decays Lepton Number Violationhep-ex010308 nuclear & particles physicsS010:Desig=19CERN SPSK mesonLepton numberK+ --> pi- electron positronKaon Physics; Lepton Flavour Violation; NA62S010.19lcsh:Physicsexperimental results
researchProduct

Search for heavy neutrinos in K + → μ + ν μ decays

2017

The NA62 experiment recorded a large sample of K+→μ+νμ decays in 2007. A peak search has been performed in the reconstructed missing mass spectrum. In the absence of a signal, limits in the range 2×10−6 to 10−5 have been set on the squared mixing matrix element |Uμ4|2 between muon and heavy neutrino states, for heavy neutrino masses in the range 300–375 MeV/ c2 . The result extends the range of masses for which upper limits have been set on the value of |Uμ4|2 in previous production search experiments.

PhysicsNuclear and High Energy PhysicsRange (particle radiation)Particle physicsMuon010308 nuclear & particles physicsPhysics beyond the Standard ModelHeavy neutrinoNA62 experiment01 natural scienceslcsh:QC1-999Heavy neutrinos; Kaon decays; Nuclear and High Energy PhysicsNuclear physicsKaon decayHeavy neutrinos0103 physical sciencesMass spectrumKaon decaysNeutrinoHeavy neutrino010306 general physicslcsh:PhysicsMixing (physics)
researchProduct

Replacement therapy for bleeding episodes in factor VII deficiency: A prospective evaluation

2013

Patients with inherited factor VII (FVII) deficiency display different clinical phenotypes requiring ad hoc management. This study evaluated treatments for spontaneous and traumatic bleeding using data from the Seven Treatment Evaluation Registry (STER). One-hundred one bleeds were analysed in 75 patients (41 females; FVII coagulant activity <1-20%). Bleeds were grouped as haemarthroses (n=30), muscle/subcutaneous haematomas (n=16), epistaxis (n=12), gum bleeding (n=13), menorrhagia (n=16), central nervous system (CNS; n=9), gastrointestinal (GI; n=2) and other (n=3). Of 93 evaluable episodes, 76 were treated with recombinant, activated FVII (rFVIIa), eight with fresh frozen plasma (FFP), s…

MaleRegistrieTime FactorsFactor VII Deficiency030204 cardiovascular system & hematologyReplacement therapyProspective evaluationchemistry.chemical_compound0302 clinical medicineMedicineProspective StudiesRegistriesYoung adultProspective cohort studyFactor VII deficiencyChildHematologyFactor VIIHematologyMiddle AgedRecombinant ProteinBlood Coagulation FactorsRecombinant ProteinsTreatment OutcomeCoagulantChild PreschoolFemaleBlood Coagulation FactorHumanAdultmedicine.medical_specialtyAdolescentTime FactorHemorrhageBlood Component TransfusionFactor VIIaBleeds; Factor VII deficiency; Replacement therapy; Adolescent; Adult; Aged; Blood Coagulation Factors; Child; Child Preschool; Coagulants; Drug Administration Schedule; Factor VII Deficiency; Factor VIIa; Female; Hemorrhage; Humans; Infant; Infant Newborn; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Registries; Time Factors; Treatment Outcome; Young Adult; Blood Component Transfusion; HematologyDrug Administration Schedule03 medical and health sciencesYoung AdultInternal medicineHumansAgedBleeding episodesbusiness.industryCoagulantsInfant NewbornInfantSurgeryProspective StudieTreatment evaluationchemistryBleedbusiness030215 immunology
researchProduct

Search for heavy neutral lepton production in K+ decays to positrons

2020

A search for heavy neutral lepton ($N$) production in $K^+\to e^+N$ decays using the data sample collected by the NA62 experiment at CERN in 2017--2018 is reported. Upper limits of the extended neutrino mixing matrix element $|U_{e4}|^2$ are established at the level of $10^{-9}$ over most of the accessible heavy neutral lepton mass range 144--462 MeV/$c^2$, with the assumption that the lifetime exceeds 50 ns. These limits improve significantly upon those of previous production and decay searches. The $|U_{e4}|^2$ range favoured by Big Bang Nucleosynthesis is excluded up to a mass of about 340 MeV/$c^2$.

AstrofísicaNuclear and High Energy PhysicsHeavy neutral lepton kaon meson kaon decay positronPontecorvo–Maki–Nakagawa–Sakata matrixSocio-culturaleFOS: Physical sciencesNA62 experiment7. Clean energy01 natural sciencesNA62High Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)Positronkaon decays heavy neutral lepton SM extensionsPE2_2Big Bang nucleosynthesisSM extensionskaon physics0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]010306 general physicsComputingMilieux_MISCELLANEOUSPhysicsRange (particle radiation)Large Hadron Colliderkaon decays010308 nuclear & particles physicshep-exSettore FIS/04Heavy neutral leptonlepton flavour violationFísicalcsh:QC1-999kaon mesonkaon decaykaon physics; lepton flavour violation; NA62positronProduction (computer science)High Energy Physics::Experimentkaonlcsh:PhysicsParticle Physics - ExperimentLepton
researchProduct

Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)

2013

WOS: 000319897700018

RegistrieSevere bleedingAdultMalePediatricsmedicine.medical_specialtyTime FactorsTime FactorAdolescentFactor VII DeficiencyPROPHYLAXIS FACTOR VII DEFICIENCYFactor VIIachemistry.chemical_compoundPlasmaYoung AdultMedicineHumansRegistriesYoung adultFactor VII deficiencyChildFactor VIIbusiness.industryInfantHematologyRecombinant ProteinFactor VIIMiddle Agedmedicine.diseaseThrombosisRecombinant ProteinsClinical trialTreatment OutcomechemistryTreatment evaluationWeekly doseChild PreschoolFemaleOriginal Articles and Brief ReportsbusinessHuman
researchProduct

Search for K+→ π+νν¯ at NA62

2018

Flavour physics is one of the most powerful fields for the search of new physics beyond the Standard Model. The kaon sector with the rare decay K+ → π+νν̅ provides one of the cleanest and most promising channels. NA62, a fixed target experiment at the CERN SPS, aims to measure BR (K+ → π+νν̅) with 10% precision to test the Standard Model validity up to an energy scale of hundreds of TeV. NA62 had dedicated data taking for the K+ → π+νν̅ measurement in 2016 and 2017 and will continue in 2018. Here preliminary results on a fraction of 2016 dataset are presented. The analysis of the complete 2016 data sample is expected to achieve the SM sensitivity.

PhysicsParticle physicsLarge Hadron Collider010308 nuclear & particles physicsPhysics beyond the Standard ModelPhysicsQC1-999Flavour Physicsrare Kaon decays01 natural sciencesMeasure (mathematics)Settore FIS/04 - Fisica Nucleare e SubnucleareStandard ModelPhysics and Astronomy (all)0103 physical sciences010306 general physicsFlavour Physics rare Kaon decays
researchProduct

The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Pl…

2021

Background: The ISTH Bleeding Assessment Tool (ISTH-BAT) has been validated for clinical screening of suspected von Willebrand disease (VWD) and for bleeding prediction. Recently it has been validated for subjects with inherited platelet disorders (IPD) (BAT-VAL study). Objectives: To determine whether the ISTH-BAT bleeding score (BS) predicts subsequent bleeding events requiring treatment in IPD patients. Methods: Patients with IPD, type 1 VWD (VWD-1) and age- and sex-matched healthy controls enrolled in the BAT-VAL study were prospectively followed-up for 2 years and bleeding episodes requiring treatment were recorded. Results: Of the 1098 subjects initially enrolled, 955 were followed-up…

medicine.medical_specialtyanimal structuresmild&#8208Platelet Function TestsPlatelet disorderinherited platelet disorderHemorrhage030204 cardiovascular system & hematologyHemorrhage/diagnosis03 medical and health sciences0302 clinical medicineVon Willebrand factorhemic and lymphatic diseasesInternal medicinevon Willebrand FactorVon Willebrand diseaseMedicineHumansPlateletBleeding prediction Bleeding score Blood platelet disorders Child Communication Hemorrhage Humans Inherited platelet disorders Mild-moderate bleeding disorders Platelet Function Tests von Willebrand diseases von Willebrand FactorChildBlood Platelet Disordersddc:616mild-moderate bleeding disordersbiologybusiness.industrymild-moderate bleeding disorderIncidence (epidemiology)CommunicationSettore MED/09 - MEDICINA INTERNAbleeding predictionvon Willebrand Diseases/diagnosis/genetics[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyHematologymedicine.diseaseBlood Platelet Disorders/diagnosis/genetics3. Good healthbleeding scoreInstitutional repositoryvon Willebrand Diseasesmoderate bleeding disordersinherited platelet disordersQuartilebiology.proteinBlood Platelet Disordersvon Willebrand diseasebusinessJournal of thrombosis and haemostasis : JTHREFERENCES
researchProduct

NA48/62 latest results

2017

The NA62 experiment at the CERN SPS recorded in 2007 a large sample of K+ ? µ+?µ decays. A peak search in the missing mass spectrum of this decay is performed. In the absence of observed signal, the limits obtained on B(K+ ? µ+?h) and on the mixing matrix element |Uµ 4| are reported. The upgraded NA62 experiment started data taking in 2015. About 5×1011K+ decays have been recorded so far to measure the branching ratio of the K+ ? ?+?? decay. Preliminary results from the K+ ? ?+?? analysis based on about 5% of the 2016 statistics are reported.

Nuclear physicsPhysicsParticle physicsBranching fractionTheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITYMass spectrumMatrix elementCreative commonsNA62 experimentParticle Physics - ExperimentSettore FIS/04 - Fisica Nucleare e SubnucleareLarge sample
researchProduct

Hereditary combined deficiency of the vitamin K-dependent clotting factors

2010

Abstract Hereditary combined vitamin K-dependent clotting factors deficiency (VKCFD) is a rare congenital bleeding disorder resulting from variably decreased levels of coagulation factors II, VII, IX and X as well as natural anticoagulants protein C, protein S and protein Z. The spectrum of bleeding symptoms ranges from mild to severe with onset in the neonatal period in severe cases. The bleeding symptoms are often life-threatening, occur both spontaneously and in a surgical setting, and usually involve the skin and mucosae. A range of non-haemostatic symptoms are often present, including developmental and skeletal anomalies. VKCFD is an autosomal recessive disorder caused by mutations in …

Vitaminmedicine.medical_specialtyVitamin KCoagulation Factor Deficiencylcsh:MedicineReviewGastroenterologyProtein SProtein SSettore MED/15 - Malattie Del Sanguechemistry.chemical_compoundBlood Coagulation Disorders InheritedInternal medicineVitamin K deficiencymedicineHumansGenetics(clinical)Pharmacology (medical)VITAMIN K DEPENDENT CLOTTING FACTORS RARE INHERITED BLEEDING DISORDERSCongenital Bleeding DisorderGenetics (clinical)Medicine(all)Clotting factorbiologybusiness.industrylcsh:RVitamin K2WarfarinInfant NewbornGeneral MedicineBlood Proteinsmedicine.diseaseBlood Coagulation FactorsRecombinant ProteinschemistryCarbon-Carbon LigasesImmunologybiology.proteinVitamin K Deficiencybusinessmedicine.drugProtein C
researchProduct

The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes

2015

Background. Critically ill patients appear to be at high risk of developing deep vein thrombosis (DVT) and pulmonary embolism during their stay in the intensive care unit (ICU). However, little is known about the clinical course of venous thromboembolism in the ICU setting. We therefore evaluated, through a systematic review of the literature, the available data on the impact of a diagnosis of DVT on hospital and ICU stay, duration of mechanical ventilation and mortality in critically ill patients. We also tried to determine whether currently adopted prophylactic measures need to be revised and improved in the ICU setting. Materials and methods. MEDLINE and EMBASE databases were searched up…

RiskCritical IllnessIntensive Care UnitCritically ill patients; Deep vein thrombosis; Meta-analysis; Outcomes; Cohort Studies; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Pulmonary Embolism; Randomized Controlled Trials as Topic; Research Design; Respiration Artificial; Risk; Thrombophilia; Treatment Outcome; Venous Thrombosis; Critical Illness; Hematology; Immunology and AllergyReviewDeep Vein Thrombosis Critically Ill Patients outcomes metanalysisCohort StudiesDeep vein thrombosiImmunology and AllergyHumansThrombophiliaMeta-analysiVenous ThrombosiHospital MortalityOutcomeRandomized Controlled Trials as TopicVenous ThrombosisHematologyLength of StayRespiration ArtificialIntensive Care UnitsTreatment OutcomeResearch DesignCritical IllneCritically ill patientCohort StudiePulmonary EmbolismHuman
researchProduct

Search for the decay ϕ→K0K¯0γ with the KLOE experiment

2009

Abstract We have searched for the decay ϕ → K 0 K ¯ 0 γ , by detecting K S pairs plus a photon and with the K S -mesons decaying to π + π − , in a sample of about 1.5 × 10 9 ϕ-decays collected by the KLOE experiment at DAΦNE. The reaction proceeds through the intermediate states f 0 ( 980 ) γ , a 0 ( 980 ) γ . We find five events with 3.2 events expected from background processes. We obtain the upper limit: BR ( ϕ → K 0 K ¯ 0 γ ) 1.9 × 10 − 8 at 90% CL.

PhysicsNuclear physicsNuclear and High Energy PhysicsTheoretical physicsPhotonMesonLimit (mathematics)Bar (unit)Physics Letters B
researchProduct

Search for heavy neutral lepton production in K+ decays

2018

A search for heavy neutral lepton production in $K^+$ decays using a data sample collected with a minimum bias trigger by the NA62 experiment at CERN in 2015 is reported. Upper limits at the $10^{-7}$ to $10^{-6}$ level are established on the elements of the extended neutrino mixing matrix $|U_{\ell 4}|^2$ ($\ell=e,\mu$) for heavy neutral lepton mass in the range $170-448~{\rm MeV}/c^2$. This improves on the results from previous production searches in $K^+$ decays, setting more stringent limits and extending the mass range.

Nuclear and High Energy PhysicsleptonPontecorvo–Maki–Nakagawa–Sakata matrixheavy neutral leptons neutrino mixingFOS: Physical sciencesk mesonNA62 experiment01 natural sciencesneutrino mixingSettore FIS/04 - Fisica Nucleare e SubnuclearedecayHigh Energy Physics - ExperimentNuclear physicsneutrinoHigh Energy Physics - Experiment (hep-ex)Minimum biasEconomicaBounds; neutrinos; masses; testsTheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITY0103 physical sciencesheavy neutral leptonslepton k meson decay neutrino010306 general physicsNuclear ExperimentPhysicsRange (particle radiation)Large Hadron Collider010308 nuclear & particles physicshep-exHigh Energy Physics::PhenomenologyAmbientalelcsh:QC1-999High Energy Physics::Experimentlcsh:PhysicsParticle Physics - ExperimentLepton
researchProduct

Precision measurement of the K S meson lifetime with the KLOE detector

2010

Using a large sample of pure, slow, short lived K0 mesons collected with KLOE detector at DaFne, we have measured the KS lifetime. From a fit to the proper time distribution we find tau = (89.562 +- 0.029_stat +- 0.043_syst) ps. This is the most precise measurement today in good agreement with the world average derived from previous measurements. We observe no dependence of the lifetime on the direction of the Ks.

PhysicsHigh Energy Physics - Experiment (hep-ex)Particle physicsPhysics and Astronomy (miscellaneous)MesonDetectorFOS: Physical sciencesProper timeHigh Energy Physics::ExperimentEngineering (miscellaneous)High Energy Physics - ExperimentLarge sampleThe European Physical Journal C
researchProduct

Phenotypic APC resistance as a marker of hypercoagulability in primitive cerebral lymphoma

2005

Thrombosis is the most frequent complication and the second cause of death in patients with malignant disease. Primary central nervous system non-Hodgkin's lymphoma represents a rare pathology. Resistance to APC is usually linked to a factor V (FV) gene mutation changing an Arg 506 to a Gln in the APC cleavage site.In our study, we aimed at investigating the presence of activated protein C resistance (APC-r) and other markers of hypercoagulability in 25 selected patients with a diagnosis of primitive cerebral lymphoma who had suffered from an ischemic episode of TIA and/or stroke.25 selected patients with a diagnosis of primitive cerebral lymphoma and 50 healthy subjects acted as control gr…

Brain NeoplasmsLymphoma Non-HodgkinFactor VPeptide FragmentsBrain NeoplasmStrokePhenotypePeptide FragmentIschemic Attack TransientCase-Control StudiesMutationPlasminogen Activator Inhibitor 1HumansProthrombinCase-Control StudieBlood CoagulationBiomarkersHumanActivated Protein C Resistance
researchProduct

VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY

2008

Summary.  Background: Combined vitamin K-dependent clotting factor (VKCF) deficiency type 2 (VKCFD2) is a rare bleeding disorder caused by mutated vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1) gene. Methods and results: An Italian patient with moderate to severe bleeding tendency was genotyped, and found to be homozygous for the unique VKORC1 mutation (Arg98Trp) so far detected in VKCFD2. The activity levels of VKCFs were differentially reduced, and inversely related to the previously estimated affinity of procoagulant factor propeptides for the γ-carboxylase. The normal (factor IX) or reduced antigen levels (other VKCFs) produced a gradient in specific activities. Vitamin K su…

Adultmedicine.medical_specialtycoagulation factor levelsVitamin KProtein SMixed Function OxygenasesTissue factorchemistry.chemical_compoundInternal medicineVitamin K Epoxide ReductasesmedicineVKCFD2HumansFactor IXClotting factorCoagulation factor levels; Thrombin generation; Vitamin K supplementation; VKCFD2; VKORC1 mutation;biologyFactor VIIChemistryFactor XHomozygotevitamin K supplementationHematologyBlood Coagulation DisordersEndocrinologyTreatment OutcomeCoagulationthrombin generationImmunologyMutationbiology.proteinFemaleBlood Coagulation TestsVKCFD2 VKORC1 mutation coagulation factor levels thrombin generation vitamin K supplementationProtein Cmedicine.drugHalf-LifeVKORC1 mutation
researchProduct

Search for Lepton Number and Flavor Violation in K+ and π0 Decays

2021

Searches for the lepton number violating $K^{+} \rightarrow \pi^{-} \mu^{+} e^{+}$ decay and the lepton flavour violating $K^{+} \rightarrow \pi^{+} \mu^{-} e^{+}$ and $\pi^{0} \rightarrow \mu^{-} e^{+}$ decays are reported using data collected by the NA62 experiment at CERN in $2017$-$2018$. No evidence for these decays is found and upper limits of the branching ratios are obtained at 90% confidence level: $\mathcal{B}(K^{+}\rightarrow\pi^{-}\mu^{+}e^{+})<4.2\times 10^{-11}$, $\mathcal{B}(K^{+}\rightarrow\pi^{+}\mu^{-}e^{+})<6.6\times10^{-11}$ and $\mathcal{B}(\pi^{0}\rightarrow\mu^{-}e^{+})<3.2\times 10^{-10}$. These results improve by one order of magnitude over previous results for thes…

PhysicsParticle physics010308 nuclear & particles physicsBranching fractionHigh Energy Physics::PhenomenologyFlavourGeneral Physics and Astronomy01 natural sciencesLepton number0103 physical sciencesPiHigh Energy Physics::Experiment010306 general physicsLeptonPhysical Review Letters
researchProduct

Study of the K±→π±γγ decay by the NA62 experiment

2014

Abstract A study of the dynamics of the rare decay K ± → π ± γ γ has been performed on a sample of 232 decay candidates, with an estimated background of 17.4 ± 1.1 events, collected by the NA62 experiment at CERN in 2007. The results are combined with those from a measurement conducted by the NA48/2 Collaboration at CERN. The combined model-independent branching ratio in the kinematic range z = ( m γ γ / m K ) 2 > 0.2 is B MI ( z > 0.2 ) = ( 0.965 ± 0.063 ) × 10 − 6 , and the combined branching ratio in the full kinematic range assuming a Chiral Perturbation Theory description is B ( K π γ γ ) = ( 1.003 ± 0.056 ) × 10 − 6 . A detailed comparison of the results with the previous measurements…

PhysicsNuclear and High Energy PhysicsParticle decayPionChiral perturbation theoryNuclear magnetic resonanceMesonBranching fractionHadronAnalytical chemistryElementary particleDimensionless quantityPhysics Letters B
researchProduct

"Long term anticoagulant treatment management in patients with portal vein thrombosis at high bleeding risk"

2017

anticoagulant treatment.

BleedingPortal vein thrombosis; Thrombocytopenia;BleedingPortal vein thrombosiThrombocytopenia
researchProduct

Test of lepton flavour universality in K+→ℓ+ν decays

2011

Abstract A precision test of lepton flavour universality has been performed by measuring the ratio R K of kaon leptonic decay rates K + → e + ν and K + → μ + ν in a sample of 59 813 reconstructed K + → e + ν candidates with ( 8.71 ± 0.24 ) % background contamination. The result R K = ( 2.487 ± 0.013 ) × 10 − 5 is in agreement with the Standard Model expectation.

Nuclear physicsPhysicsNuclear and High Energy PhysicsParticle physicsFlavourWidth ratioUniversality (dynamical systems)LeptonPhysics Letters B
researchProduct

Sorafenib as a feasible therapeutic option in haemophiliacs with hepatocellular carcinoma

2010

hepatocellular carcinoma, haemophilia, treatment

SorafenibOncologymedicine.medical_specialtyhepatocellular carcinoma haemophilia treatmentbusiness.industryHematologyGeneral Medicinemedicine.diseaseHaemophiliaHepatocellular carcinomaInternal medicinemedicinebusinessGenetics (clinical)medicine.drugHaemophilia
researchProduct

Precision measurement of the ratio of the charged kaon leptonic decay rates

2013

A precision measurement of the ratio RK of the rates of kaon leptonic decays K+- --&gt; e nu and K+- --&gt; mu nu with the full data sample collected by the NA62 experiment at CERN in 2007-2008 is reported. The result, obtained by analysing ~150000 reconstructed K+- --&gt; e nu candidates with 11% background contamination, is RK = (2.488+-0.010)*10^{-5}, in agreement with the Standard Model expectation.

Nuclear and High Energy PhysicsParticle physicsstandard modelFOS: Physical sciencesNA62 experiment01 natural sciencesHigh Energy Physics - ExperimentStandard ModelNuclear physicsHigh Energy Physics - Experiment (hep-ex)lepton universalityRare kaon decays; chiral perturbation theoryLepton universality; Charged Kaon Decay0103 physical scienceskaon decays leptonic decays lepton universality010306 general physicschiral perturbation theoryPhysicsleptonic decaysLarge Hadron Colliderkaon decays010308 nuclear & particles physicscharged kaon3. Good healthCharged Kaon DecayRare kaon decaysKaon rare decaysFull dataKaon rare decays; branching ratio; charged kaon; leptonic decays; standard modelbranching ratioParticle Physics - ExperimentLepton universality
researchProduct

Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER

2010

Excessive bleeding represents a major complication of surgical interventions and its control is especially relevant in patients with Congenital Bleeding Disorders (CBD). In factor VII (FVII) deficiency, scanty data on surgery is available to guide treatment strategies. The STER (Seven Treatment Evaluation Registry) is a multi-centre, prospective, observational, web-based study protocol providing the frame for a structured and detailed data collection. Inhibitor occurrence was checked in a centralized fashion. Forty-one surgical operations (24 'major' and 17 'minor') were performed in 34 subjects with a carefully characterized FVII deficiency under the coverage of recombinant activated Facto…

Excessive Bleedingmedicine.medical_specialtyHematologyFactor VIIbusiness.industrymedicine.medical_treatmentHematologymedicine.diseaseSurgerychemistry.chemical_compoundDental extractionchemistryInternal medicineHemostasisOrthopedic surgerymedicineCoagulopathyProspective cohort studybusinessBritish Journal of Haematology
researchProduct

Measurement of the η→3π0 slope parameter α with the KLOE detector

2010

Abstract We present a measurement of the slope parameter α for the η → 3 π 0 decay, with the KLOE experiment at the DAΦNE ϕ -factory, based on a background free sample of ∼17 million η mesons produced in ϕ radiative decays. By fitting the event density in the Dalitz plot we determine α = − 0.0301 ± 0.0035 stat − 0.0035 + 0.0022 syst . The result is in agreement with recent measurements from hadro- and photo-production experiments.

PhysicsNuclear physicsNuclear and High Energy PhysicsParticle physicsMesonElectron–positron annihilationDetectorPiRadiative transferDalitz plotPhysics Letters B
researchProduct

Search for neutral MSSM Higgs bosons at LEP

2006

The four LEP collaborations, ALEPH, DELPHI, L3 and OPAL, have searched for the neutral Higgs bosons which are predicted by the Minimal Supersymmetric Standard Model (MSSM). The data of the four collaborations are statistically combined and examined for their consistency with the background hypothesis and with a possible Higgs boson signal. The combined LEP data show no significant excess of events which would indicate the production of Higgs bosons. The search results are used to set upper bounds on the cross-sections of various Higgs-like event topologies. The results are interpreted within the MSSM in a number of "benchmark" models, including CP-conserving and CP-violating scenarios. Thes…

AlephPARTICLE PHYSICS; LARGE ELECTRON POSITRON COLLIDER; ALEPH; DELPHI; L3; OPALPhysics and Astronomy (miscellaneous)Parameter space01 natural sciencesOPAL DETECTORHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Event (probability theory)BosonPhysicsEXPLICIT CP VIOLATIONROOT-S=189 GEVOPALFLAVOR INDEPENDENT SEARCHParticle physics - ExperimentPhysicsSettore FIS/01 - Fisica SperimentaleHiggs particle. search forSUPERGAUGE TRANSFORMATIONSALEPHLARGE ELECTRON POSITRON COLLIDERALEPH DELPHI L3 OPALSUPERSYMMETRIC STANDARD MODELROOT-SL3Higgs bosonPARTICLE PHYSICSParticle physicselectron positron. colliding beamselectron positron. annihilationFOS: Physical sciencessupersymmetric standard model;; explicit cp violation;; electric-dipole moment;; e(+)e(-) collisions;; root-s=189 gev;; opal detector;; root-s;; z(0) decays;; supergauge transformations;; radiative-correctionsHiggs particle. electroproductionddc:500.2-SUPERSYMMETRIC STANDARD MODEL; EXPLICIT CP VIOLATION; FLAVOR INDEPENDENT SEARCH; ELECTRIC-DIPOLE MOMENT; E(+)E(-) COLLISIONS; ROOT-S; ROOT-S=189 GEV; OPAL DETECTOR; Z(0) DECAYS; SUPERGAUGE TRANSFORMATIONSHiggs particleLEP colliderNext-to-Minimal Supersymmetric Standard ModelELECTRIC-DIPOLE MOMENTE(+)E(-) COLLISIONSConsistency (statistics)0103 physical sciencesddc:530High Energy Physics010306 general physicsEngineering (miscellaneous)DELPHIelectron positron010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyHiggs BosonLEPHIGGSHiggs boson standard modelZ(0) DECAYSExperimental High Energy PhysicsHigh Energy Physics::ExperimentHiggs Boson; LEP colliderMSSMMinimal Supersymmetric Standard ModelHiggs
researchProduct

Hemophilia Clinical Consults: Epidemiology, Clinical Course, and Management of Acquired Hemophilia A

2011

Acquired Haemophilia
researchProduct